[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 1985

Eosinophilic Fasciitis: A Distinct Entity?-Reply

Author Affiliations

Division of Rheumatology East Carolina University School of Medicine Greenville, NC 27834
Pediatric Rheumatology Duke University School of Medicine Durham, NC 27710

Am J Dis Child. 1985;139(1):8-9. doi:10.1001/archpedi.1985.02140030010002

In Reply.—We read with interest the letter submitted by Yarom and Levinson in response to our case report "Eosinophilic Fasciitis in the Child."1 After reviewing the clinical and laboratory characteristics of their patient, we would agree with the diagnosis of morphea and linear scleroderma. We wonder, however, whether or not the focal eosinophilia with chronic fasciitis was a secondary inflammatory response to the primary disease process of linear scleroderma, rather than eosinophilic fasciitis as described in our case. Their biopsy specimen was most consistent with localized scleroderma since they documented dermal perivasculitis and collagenosis, characteristics of a biopsy specimen not found in eosinophilic fasciitis.

Although we consider eosinophilic fasciitis to be a distinct entity from linear scleroderma, morphea, systemic sclerosis, and other collagen vascular diseases, we note that there is some overlap in clinical and laboratory findings. Eosinophilia has been described not only in eosinophilic fasciitis, but also in morphea

First Page Preview View Large
First page PDF preview
First page PDF preview